Prior studies have also shown that estrogen can increase apoptosis in RCC, while androgen and the androgen receptor (AR) can promote various aspects of tumor progression, including stemness, angiogenesis, proliferation, migration, and invasion of RCC [14–21]. The gene discussed is AR; the disease is renal cell carcinoma.